Page last updated: 2024-10-28

glimepiride and Hypergonadotropic Hypogonadism

glimepiride has been researched along with Hypergonadotropic Hypogonadism in 1 studies

glimepiride: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Men with type 2 diabetes are often characterized by abnormal plasma testosterone levels."5.43The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride. ( Gilowski, W; Krysiak, R; Okopień, B, 2016)
"Men with type 2 diabetes are often characterized by abnormal plasma testosterone levels."1.43The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride. ( Gilowski, W; Krysiak, R; Okopień, B, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krysiak, R1
Gilowski, W1
Okopień, B1

Other Studies

1 other study available for glimepiride and Hypergonadotropic Hypogonadism

ArticleYear
The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride.
    Pharmacological reports : PR, 2016, Volume: 68, Issue:1

    Topics: Aged; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; H

2016